SprintRay, best known for its chairside 3D printers, used its 3DNext 2026 event in Miami Beach to introduce an intraoral scanner; a compact print, wash and cure lineup called the Nano Series; and a new hybrid ceramic resin developed with GC America.
Foundation and ScanOS
Foundation is a wireless, full-color intraoral scanner built for ScanOS, SprintRay's scanning software. ScanOS connects to the company's cloud dashboard, so scans sit in the same account and interface a practice already uses for design and printing. SprintRay says that lets a case move from capture to finished work without exporting and uploading files along the way.
"ScanOS makes scanning a native part of the SprintRay workflow, and Foundation is the first intraoral scanner built for it," said Amir Mansouri, Ph.D., co-founder and CEO of SprintRay.
Foundation is launching first in the United States, with first shipments expected in November 2026, according to the company.
Nano Series
The Nano Series is three machines: NanoPrint, NanoWash and NanoCure. Together they take up less than 30 inches of counter space. NanoPrint uses a 385 nm light engine, NanoWash automates washing and drying, and NanoCure handles post-processing. Features called AutoPrint and Job Handoff link the steps and carry case information from one machine to the next.
SprintRay says more than 80 percent of chairside print jobs involve a single patient and case, and the smaller footprint is designed around that workload.
"With Nano Series, we have designed the print, wash and cure experience around the way chairside dentistry actually works," Mansouri said.
Nano Series shipments are expected to begin in November 2026 in the U.S., Canada, Australia, New Zealand and the European Union, subject to regional regulatory requirements. NanoWash is not part of the Canadian launch.
GC GRADIA PREMi
The third announcement is GC GRADIA PREMi, a hybrid ceramic restorative resin developed with GC Corporation for the SprintRay Midas Digital Press, the company's capsule-based chairside manufacturing system. SprintRay says clinical indications and regional availability depend on GC's final labeling and regulatory review, and availability has not yet been announced.
"Openness matters, but so does validation," Mansouri said of the company's approach to materials.
SprintRay did not announce pricing for any of the new products. The company says its ecosystem has produced more than 20 million dental parts.